Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Béatrice Dolder-Schlienger"'
Autor:
Heinz Läubli, Viktor H. Koelzer, Matthias S. Matter, Petra Herzig, Béatrice Dolder Schlienger, Mark Nikolaj Wiese, Didier Lardinois, Kirsten D. Mertz, Alfred Zippelius
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Cancer immunotherapy with antibodies targeting immune checkpoints such as the PD-1/PD-L1 pathway have emerged as breakthrough treatment for multiple solid tumors with high response rates and durable remissions. Despite the benefit for patients and en
Externí odkaz:
https://doaj.org/article/798022384f2747deb8d7739f4959e7ed
Autor:
Kirsten D. Mertz, Heinz Läubli, Petra Herzig, Didier Lardinois, Viktor H. Koelzer, Mark Wiese, Alfred Zippelius, Béatrice Dolder Schlienger, Matthias S. Matter
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Cancer immunotherapy with antibodies targeting immune checkpoints such as the PD-1/PD-L1 pathway have emerged as breakthrough treatment for multiple solid tumors with high response rates and durable remissions. Despite the benefit for patients and en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec6cd3ba63252c7a44bde8f3d3062f1
https://europepmc.org/articles/PMC5749666/
https://europepmc.org/articles/PMC5749666/
Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma
Autor:
Béatrice Dolder Schlienger, Sven Hillinger, Dario Neri, Alfred Zippelius, Spasenja Savic Prince, Sébastien Wieckowski, Teresa Hemmerle
Publikováno v:
Lung cancer (Amsterdam Netherlands)
Objectives Antibody–cytokine fusion proteins (immunocytokines) represent a novel class of armed antibodies in oncology. In particular, IL2- and TNF-based immunocytokines targeting the EDB domain of fibronectin and the A1 domain of tenascin-C have d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d41fb49dc33453719f5113e36bb37f
https://pubmed.ncbi.nlm.nih.gov/25682318
https://pubmed.ncbi.nlm.nih.gov/25682318
Autor:
Pier Morin, Daniel Maier, Brian A. Hemmings, Mihai-Constantin S. Ionescu, Martin Labuhn, Graham Jones, Béatrice Dolder-Schlienger, Jean-Louis Boulay, Maria Maddalena Lino, Balasubramanian Sivasankaran, Elisabeth Taylor, Adrian Merlo
Publikováno v:
International journal of oncology. 35(5)
Loss of heterozygosity (LOH) of the entire chromosome 10 is the most frequent genetic alteration in human glioblastoma (GBM). In addition to PTENlMMAC 1 on 10q23.3, clustering of partial deletion break-points on 1Oq25.3- 26.1 points to a second suppr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb76b95883f67e0bebcd12f4735d24b
https://pubmed.ncbi.nlm.nih.gov/19787267
https://pubmed.ncbi.nlm.nih.gov/19787267